MaxCyte, Inc.
MXCT
$2.61
$0.062.35%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 6.48% | -21.72% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 6.48% | -21.72% | |||
| Cost of Revenue | 18.31% | 29.57% | |||
| Gross Profit | 2.82% | -30.25% | |||
| SG&A Expenses | -1.96% | -2.13% | |||
| Depreciation & Amortization | -0.10% | -1.26% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.80% | -0.80% | |||
| Operating Income | 8.20% | -17.42% | |||
| Income Before Tax | 8.31% | -23.27% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 8.31% | -23.27% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 8.31% | -23.27% | |||
| EBIT | 8.20% | -17.42% | |||
| EBITDA | 8.80% | -19.29% | |||
| EPS Basic | 8.73% | -22.77% | |||
| Normalized Basic EPS | 8.59% | -22.68% | |||
| EPS Diluted | 8.73% | -22.77% | |||
| Normalized Diluted EPS | 8.59% | -22.68% | |||
| Average Basic Shares Outstanding | 0.42% | 0.45% | |||
| Average Diluted Shares Outstanding | 0.42% | 0.45% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||